These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1392 related articles for article (PubMed ID: 6329145)

  • 1. [Viral markers of hepatitis A and B: main characteristics and clinical significance].
    Lyra LG
    Arq Gastroenterol; 1983; 20(3):117-22. PubMed ID: 6329145
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Hbeag/Anti-hbe system and other markers for hepatitis b in a dialysis unit (author's transl)].
    Turci F; Iosa G; Cipolloni A; Cenciotti L
    Quad Sclavo Diagn; 1980 Dec; 16(4):349-55. PubMed ID: 7244108
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anti-hepatitis B core immunoglobulin M in the serologic evaluation of hepatitis B virus infection and simultaneous infection with type B, delta agent, and non-A, non-B viruses.
    Perrillo RP; Chau KH; Overby LR; Decker RH
    Gastroenterology; 1983 Jul; 85(1):163-7. PubMed ID: 6406288
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Determination of hepatitis B E antigens, anti-hepatitis B E and Dane particles in the serum of hepatitis B S carriers and patients with chronic hepatitis B S antigen-positive hepatitis].
    Reichlin B; Stalder GA; Gudat F; Bianchi L; Froesner GG
    Schweiz Med Wochenschr; 1982 Apr; 112(15):523-4. PubMed ID: 7079688
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Comparative study of the "e" system (HBeAG/anti-HBeAg) and core antibodies in aggressive chronic hepatitis and liver cirrhosis].
    Marinucci G; Muglia M; Di Giacomo C; Petrucci L; Mancini R; Costa F; Bachetoni A
    Quad Sclavo Diagn; 1981 Mar; 17(1):81-5. PubMed ID: 7313073
    [No Abstract]   [Full Text] [Related]  

  • 6. [Hepatitis B and hepatitis A markers in 33 cases of acute hepatitis B surface antigen-negative, hepatitis A virus antibody-positive viral hepatitis. Importance of immune complexes].
    Raise E; Bonazzi L; Cucci AM; Imbastaro T; Nucci S; Boni P; Miniero R; Lenzi G
    Minerva Med; 1982 Apr; 73(18):1169-72. PubMed ID: 6281689
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Incidence of HAV and HBc antibodies in patients with chronic hepatitis].
    Tanno H; Fay O; Roncoroni M; Galimberti B; Palazzi J
    Acta Gastroenterol Latinoam; 1980; 10(2):105-11. PubMed ID: 7211130
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Markers of type B viral hepatitis].
    Brunello F; Emanuelli G; Camussi G
    Minerva Med; 1979 Sep; 70(41):2791-800. PubMed ID: 386166
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HBeAg/anti-HBe system in the acute phase of HBsAg-positive hepatitis as a predictive test of developing chronic hepatitis.
    Caredda F; D'Arminio Monforte A; Rossi E; Cultraro D; Marescotti C; Moroni M
    Boll Ist Sieroter Milan; 1981; 60(6):468-79. PubMed ID: 7344717
    [No Abstract]   [Full Text] [Related]  

  • 10. [The behavior of the HBeAg-anti-HBe system in chronic hepatitis].
    Musca A; Cordova C; Barnaba V; Bonavita MS; Zaccari C; Levrero M
    Minerva Dietol Gastroenterol; 1983; 29(1):19-26. PubMed ID: 6843853
    [No Abstract]   [Full Text] [Related]  

  • 11. [The significance of studying the HBe system in the prognosis of patients with acute and chronic viral hepatitis Be].
    Perisić-Savić M; Nastić-Mirić D
    Srp Arh Celok Lek; 1983; 111(9-10):1343-50. PubMed ID: 6681452
    [No Abstract]   [Full Text] [Related]  

  • 12. [Relation between viral antigens in hepatic tissue detected by immunofluorescence and serological markers of HBV infection in patients with chronic hepatitis].
    Calzia R; Ciravegna B; Navone C; Tolentino P
    Boll Ist Sieroter Milan; 1982; 61(4):347-56. PubMed ID: 6765398
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Antigens and antibodies in acute viral hepatitis caused by the B virus. Clinical significance].
    Malacco E; Iacono G; Risso F
    Minerva Med; 1979 Feb; 70(6):479-82. PubMed ID: 431867
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Investigations of HBe antigen. Note I. Prevalence of HBeAg and anti-HBe in the stationary phase of HBsAg-positive acute viral hepatitis.
    Babeş VT; Tănase M; Cepănaru S; Cepănaru R
    Virologie; 1981; 32(2):93-8. PubMed ID: 6787796
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Clinical significance of HBeAg and anti-HBe in HBsAg positive liver diseases].
    Takahashi A; Sekiya C; Yazaki Y; Tominaga Y; Oohara K; Ono M; Sato H; Hasebe C; Namiki M
    Hokkaido Igaku Zasshi; 1983 Jan; 58(1):30-42. PubMed ID: 6840666
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Investigations on HBe antigen. Note II. Dynamics of HBsAg in acute viral hepatitis, according to HBeAg persistence or seroconversion.
    Babeş VT; Cepănaru S; Cepănaru R; Tănase M
    Virologie; 1981; 32(3):187-91. PubMed ID: 7303492
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HBe-Antigen in the course and prognosis of hepatitis B infection: a prospective study.
    Schulman AN; Fagen ND; Brezina M; Silver H; Nitzze A; Morton D; Gitnick GL
    Gastroenterology; 1980 Feb; 78(2):253-8. PubMed ID: 7350048
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Meaning and development of markers of acute hepatitis].
    Bonazzi L; Raise E; Cuccí AM; Ruffilli E; Lenzi G; Di Salvo S; Pittralis MC
    Minerva Med; 1982 Apr; 73(18):1161-8. PubMed ID: 6281688
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Hepatitis B: serological strategy and epidemiological aspects].
    Penna R; Rabagliati AM
    G Batteriol Virol Immunol; 1981; 74(1-6):145-62. PubMed ID: 7030851
    [No Abstract]   [Full Text] [Related]  

  • 20. Viral hepatitis, type B. Studies on natural history and prevention re-examined.
    Krugman S; Overby LR; Mushahwar IK; Ling CM; Frösner GG; Deinhardt F
    N Engl J Med; 1979 Jan; 300(3):101-6. PubMed ID: 758598
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 70.